Overview

Onxeo SA is a clinical-stage biotechnology company specializing in the development of innovative drugs for oncology. The company is focused on the development of unique therapeutic options aimed at improving cancer treatment outcomes using a diversified approach.

Therapeutic areas

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Onxeo SA in our records. PharmaTek screens the full directory against live FDA enforcement data.

Verified Supplier Partner

Is this Onxeo SA? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.